Last reviewed · How we verify
A Phase I/II Clinical Study Using Pentamidine in Patients With Locally Advanced or Metastatic Pancreatic Cancer Undergoing Standard Therapy
The purpose of this study is to investigate the safety and possible efficacy of the use of pentamidine in the treatment of pancreatic cancer metastasis in subjects receiving standard therapy.
Details
| Lead sponsor | Oncozyme Pharma Inc. |
|---|---|
| Phase | Phase 1/Phase 2 |
| Status | COMPLETED |
| Enrolment | 10 |
| Start date | 2009-01 |
| Completion | 2011-06 |
Conditions
- Pancreatic Cancer
Interventions
- Pentamidine
Primary outcomes
- Any severe events, tumor marker CA19-9, and tumor size (CT scan) — 6 months
Countries
Canada